Catalog No.
MGK61509
Species reactivity
General
Host species
Mouse
Isotype
IgG
Clonality
Monoclonal
Immunogen
Clobetasol Propionate/CBP conjugated to carrier protein.
Endotoxin level
Please contact with the lab for this information.
Purification
Protein A/G purified from cell culture supernatant.
Accession
25122-46-7
Applications
ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
17-propionate;cgp9555;Clobetasol17-propionatesolution,100ppm;Clo β solpropionate;21-Chloro-9-fluoro-11b,17-dihydroxy-16b-methylpregna-1,4-diene-3,20-dione17-propionate;CLOBETASOL17-PROPIONATEUSP;[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]propanoate;Dermovate
Clone ID
1A488
From Prescription to Predicament: A Case of Semaglutide-Induced Discoid Lupus Erythematosus in an Adult Male Patient., PMID:40330408
A scientometric study on research trends and characteristics of discoid lupus erythematosus., PMID:39873055
Resolution of Bullous Pemphigoid Following Lung Cancer Resection: A Case of Paraneoplastic Pemphigoid., PMID:39669836
Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn's disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy., PMID:39105861
PD-1 Inhibitor Induced Hypertrophic Lichen Planus: A Case Report., PMID:38877280
Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein., PMID:38508975
Anti-laminin 332 antibodies in graft-versus-host disease-associated bullous pemphigoid after allogeneic peripheral blood stem cell transplantation., PMID:38478637
Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation., PMID:37940861
Ganciclovir-induced drug reaction with eosinophilia and systemic symptoms., PMID:37799364
Fixed-combination halobetasol propionate and tazarotene topical lotion decreases TNF-α and IL-17A levels in psoriatic lesions., PMID:37577786
Azithromycin as a Possible Cause of Linear IgA Bullous Dermatosis., PMID:37288175
Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated in symptoms after secukinumab: case report., PMID:36324078
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations., PMID:36254548
The Effect and Mechanism of Burnet Gels on Steroid-Dependent Dermatitis in Guinea Pig Model., PMID:36147631
Halobetasol Propionate 0.01% Lotion for Plaque Psoriasis and Corticosteroid-Responsive Dermatoses., PMID:35533304
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar., PMID:34477078
Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options., PMID:34369370
Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders., PMID:33841390
Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs., PMID:33484964
PD1 inhibitor induced inverse lichenoid eruption: a case series., PMID:33423421
Annular atrophic lichen planus induced by anti-HER2 antibodies., PMID:33216943
Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature., PMID:32772795
Treatment options for autoimmune bullous dermatoses other than systemic steroids: A systematic review and network meta-analysis., PMID:32558137
Dermatomal necrotizing infundibular crystalline folliculitis following herpes zoster in a patient on PD-1 inhibitor therapy., PMID:32428371
Bullous dermatoses secondary to anti-PD-L1 agents: a case report and review of the literature., PMID:31735006
Drug updates and approvals: 2019 in review., PMID:31658218
Linagliptin-associated bullous pemphigoid treated with rituximab., PMID:31570343
Multiple Keratoacanthoma-like Lesions in a Patient Treated with Pembrolizumab., PMID:31449315
Nivolumab-induced lichen planus., PMID:31382865
Dermatitis Herpetiformis: Novel Perspectives., PMID:31244841
A catastrophic vulvar ulcer., PMID:31233709
Methotrexate is safe and efficient as long-term treatment for bullous pemphigoid., PMID:30734720
A Case of Ixekizumab-induced Psoriasiform Eruption., PMID:30723870
Immune checkpoint inhibitor-related alopecia: Insight into the pathophysiology utilizing non-invasive diagnostic techniques., PMID:30614046
Multiple eruptive cutaneous horns on the scalp., PMID:30604475
[Bullous pemphigoid, a dermatosis of the elderly]., PMID:30512605
Nivolumab PD-1 inhibitor immunotherapy associated with vulvar, perineal and perianal lichen sclerosus., PMID:30430637
Adjuvant treatment of severe/refractory bullous pemphigoid with protein A immunoadsorption., PMID:30179319
A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management., PMID:30018132
In vivo optical coherence tomography imaging in a case of mucous membrane pemphigoid and a negative Nikolsky's sign., PMID:29479786
Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma., PMID:29389067
Phototoxic drug reaction with the novel agent rovalpituzumab tesirine., PMID:29319846
Idiopathic chilblains in myelomonocytic leukemia: not a simple association., PMID:29318596
Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma., PMID:29222829
Infliximab-induced acne and acute localized exanthematous pustulosis: Case report., PMID:28976720
Cortisol Homeostasis in the Epidermis is Influenced by Topical Corticosteroids in Patients with Atopic Dermatitis., PMID:28794569
Cutaneous Kaposi sarcoma during treatment with superpotent topical steroids and methotrexate for bullous pemphigoid: three cases., PMID:28659250
Development of bullous pemphigoid during secukinumab treatment for psoriasis., PMID:28543960
Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy., PMID:28467522
Nodular mucinosis associated with light-chain monoclonal gammopathy of uncertain significance., PMID:27979308
For research use only. Not for human or drug use.
